Vista Pharmaceuticals Ltd — Important, 29-05-2026: Company Update

Vista Pharmaceuticals has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by a Practicing Company Secretary, confirms the company's compliance with applicable regulatory provisions and guidelines during the review period. This update signifies sound corporate governance, with no reported deviations from regulations, and highlights the company's adherence to compliance standards, which is a positive for investors.